Jacopo Parizzi: Roche’s Non-Malignant Hematology Team Is Looking Ahead to 2027
Jacopo Parizzi, Non-Malignant Haematology and Nephro-Rheumatology Unit Head at Roche, shared on LinkedIn:
”Looking toward 2027 with a clear vision and an unwavering commitment to patients!
The Roche Italy Non-Malignant Hematology team recently spent two intense and inspiring days together.
Our goal? To map out our strategy and design our commitment for 2027, ensuring we continue to pioneer solutions that truly matter.
Every discussion, brainstorm, and plan we created was driven by a single, powerful mission: to make a meaningful difference in the lives of patients living with Hemophilia A and Paroxysmal Nocturnal Hemoglobinuria (PNH).
By looking ahead and working together, we transform our dedication into concrete impact for the healthcare community and the people who inspire our work every day.
Proud of this passionate team and incredibly excited for the future we are building together!”
Stay updated with Hemostasis Today.
-
Oct 9, 2026, 10:40What New U.S. Data Reveal About GT – Glanzmann’s Research Foundation
-
Oct 9, 2026, 10:32Anjali Pandey: The Morphologic Clues to MDS With del(5q)
-
Oct 9, 2026, 10:13Reza Shojaei: 5 Leadership Responsibilities for a Sustainable Plasma Ecosystem
-
Oct 9, 2026, 08:38Johannes Gratz: Perioperative Care in Factor VII Deficiency – Treating the Patient, Not the Number
-
Oct 9, 2026, 08:28Ghanim Fajish: Vascular Cells May Retain a Prothrombotic Memory of Oxidative Stress
-
Oct 9, 2026, 07:43Mehmet Cilingiroglu: The First Diagnosis of Coronary Thrombosis in a Living Patient
-
Oct 9, 2026, 07:21Federico Ravaioli: 40 kPa Spleen Stiffness May Help Avoid Endoscopy in Chronic PVT
-
Oct 9, 2026, 07:00Danny Reardon: Closing the Global Awareness Gap on Blood Clots
-
Oct 9, 2026, 00:54Mary Catherine Moffett: Advancing Advocacy Together – Highlights from the Sanofi Bleeding Disorders Summit